Episode
Thomas Phillips: I’m Against the FDA’s Drug Approval Process | 05-30-26
- Podcast
- 77 WABC MiniCasts
- Published
- May 30, 2026
- Duration seconds
- 522
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/77-wabc-minicasts-5907352/episodes/thomas-phillips-i-m-against-the-fda-s-drug-approval-process-05-30-26/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/77-wabc-minicasts-5907352/thomas-phillips-i-m-against-the-fda-s-drug-approval-process-05-30-26.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Thomas Phillips argues that the lengthy FDA drug approval process is a significant barrier to both public health and economic growth. While the government successfully evaluates product safety quickly, the authors contend that the secondary mandate to prove long-term effectiveness creates a "one-size-fits-all" bureaucratic delay that can last a decade. By shortening this timeline and allowing the private sector and individual patients to determine a treatment's utility, the study suggests the United States could unlock up to $48 trillion in economic benefits. Learn more about your ad choices. Visit megaphone.fm/adchoices